EW Stock Summary and Trading Ideas (Edwards Lifesciences | NYSE:EW)

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

Edwards Lifesciences trades on the NYSE stock market under the symbol EW.

As of June 5, 2026, EW stock price declined to $85.96 with 5,148,828 million shares trading.

EW has a beta of 0.58, meaning it tends to be less sensitive to market movements. EW has a correlation of 0.08 to the broad based SPY ETF.

EW has a market cap of $49.50 billion. This is considered a Large Cap stock.

Last quarter Edwards Lifesciences reported $2 billion in Revenue and $.78 earnings per share. This beat revenue expectation by $54 million and exceeded earnings estimates by $.05.

In the last 3 years, EW traded as high as $96.12 and as low as $58.93.

The top ETF exchange traded funds that EW belongs to (by Net Assets): VTI, VOO, VO, IVV, SPY.

EW has underperformed the market in the last year with a return of +10.4%, while the SPY ETF gained +25.0%. In the last 3 month period, EW fell short of the market, returning +0.9%, while SPY returned +7.9%. However, in the most recent 2 weeks EW has outperformed the stock market by returning +3.3%, while SPY returned -0.7%.

EW support price is $85.73 and resistance is $89.18 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EW shares will trade within this expected range on the day.